- Oxaliplatin-rapamycin combination was superior to mono-drug in treatm…
Number of the records: 1  

Oxaliplatin-rapamycin combination was superior to mono-drug in treatment of hepatocellular carcinoma both in vitro and in vivo

  1. TitleOxaliplatin-rapamycin combination was superior to mono-drug in treatment of hepatocellular carcinoma both in vitro and in vivo / X. Z. Li ... [et al.]
    Another responsib. Li, X. Z. (Author)
    Translated titleKombinácia oxaliplatina-rapamycín bola lepšia ako monoterapia v liečbe hepatocelulárneho karcinómu ako in vitro, tak in vivo
    Phys.des.ilustr., grafy
    NoteBibliogr. odkazy
    In Neoplasma. -- ISSN 0028-2685. -- Vol. 63, no. 6 (2016), s. 880-887
    Call numberC 720
    MeSH Subject karcinóm hepatocelulárny - farmakoterapia - metabolizmus
    sirolimus - použitie terapeutické
    zlúčeniny platiny
    farmakoterapia kombinovaná
    proliferácia buniek
    apoptóza - účinky liekov
    proteíny regulujúce apoptózu
    Hep G2 bunky
    línia bunková nádorová
    testy protinádorového účinku na xenoimplantátových modeloch
    myši
    Keywords kombinácia oxaliplatina a rapamycín
    LanguageEnglish
    CountrySlovakia
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.